p.78 抽出テキスト
European Association for Cardio-Thoracic Surgery (EACTS). Europace 2020;22: 515–549. https://doi.org/10.1093/europace/euz246 131. Tagliari AP, Steckert GV, da Silveira LMV, Kochi AN, Wender OCB. Infective endocarditis profile, prognostic factors and in-hospital mortality: 6-year trends from a tertiary university center in South America. J Card Surg 2020;35:1905–1911. https://doi.org/10. 1111/jocs.14787 132. Schranz AJ, Fleischauer A, Chu VH, Wu LT, Rosen DL. Trends in drug use-associated infective endocarditis and heart valve surgery, 2007 to 2017: a study of statewide discharge data. Ann Intern Med 2019;170:31–40. https://doi.org/10.7326/M18-2124 133. Rudasill SE, Sanaiha Y, Mardock AL, Khoury H, Xing H, Antonios JW, et al. Clinical outcomes of infective endocarditis in injection drug users. J Am Coll Cardiol 2019;73: 559–570. https://doi.org/10.1016/j.jacc.2018.10.082 134. Mori M, Brown KJ, Bin Mahmood SU, Geirsson A, Mangi AA. Trends in infective endocarditis hospitalizations, characteristics, and valve operations in patients with opioid use disorders in the United States: 2005–2014. J Am Heart Assoc 2020;9:e012465. https://doi.org/10.1161/JAHA.119.012465 135. Geirsson A, Schranz A, Jawitz O, Mori M, Feng L, Zwischenberger BA, et al. The evolving burden of drug use associated infective endocarditis in the United States. Ann Thorac Surg 2020;110:1185–1192. https://doi.org/10.1016/j.athoracsur.2020.03.089 136. Mestres CA, Pare JC, Miro JM; Working Group on Infective Endocarditis of the Hospital Clínic de Barcelona. Organization and functioning of a multidisciplinary team for the diagnosis and treatment of infective endocarditis: a 30-year perspective (1985–2014). Rev Esp Cardiol (Engl Ed) 2015;68:363–368. https://doi.org/10.1016/j. recesp.2014.10.007 137. Erba PA, Lancellotti P, Vilacosta I, Gaemperli O, Rouzet F, Hacker M, et al. Recommendations on nuclear and multimodality imaging in IE and CIED infections. Eur J Nucl Med Mol Imaging 2018;45:1795–1815. https://doi.org/10.1007/s00259- 018-4025-0 138. Schwiebert R, Baig W, Wu J, Sandoe JAT. Diagnostic accuracy of splinter haemorrhages in patients referred for suspected infective endocarditis. Heart 2022. https:// doi.org/10.1136/heartjnl-2022-321052 139. Grable C, Yusuf SW, Song J, Viola GM, Ulhaq O, Banchs J, et al. Characteristics of infective endocarditis in a cancer population. Open Heart 2021;8:e001664. https://doi. org/10.1136/openhrt-2021-001664 140. Perez de Isla L, Zamorano J, Lennie V, Vazquez J, Ribera JM, Macaya C. Negative blood culture infective endocarditis in the elderly: long-term follow-up. Gerontology 2007;53: 245–249. https://doi.org/10.1159/000101691 141. Wong CY, Zhu W, Aurigemma GP, Furukawa N, Teshale EH, Huang YA, et al. Infective endocarditis among persons aged 18–64 years living with human immunodeficiency virus, hepatitis C infection, or opioid use disorder, United States, 2007–2017. Clin Infect Dis 2021;72:1767–1781. https://doi.org/10.1093/cid/ciaa372 142. N’Guyen Y, Duval X, Revest M, Saada M, Erpelding ML, Selton-Suty C, et al. Time interval between infective endocarditis first symptoms and diagnosis: relationship to infective endocarditis characteristics, microorganisms and prognosis. Ann Med 2017;49: 117–125. https://doi.org/10.1080/07853890.2016.1235282 143. Niederman MS, Baron RM, Bouadma L, Calandra T, Daneman N, DeWaele J, et al. Initial antimicrobial management of sepsis. Crit Care 2021;25:307. https://doi.org/10. 1186/s13054-021-03736-w 144. Snipsoyr MG, Ludvigsen M, Petersen E, Wiggers H, Honore B. A systematic review of biomarkers in the diagnosis of infective endocarditis. Int J Cardiol 2016;202:564–570. https://doi.org/10.1016/j.ijcard.2015.09.028 145. Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis–prospective cohort study. Arch Intern Med 2009;169:463–473. https://doi.org/10.1001/archinternmed.2008.603 146. Amat-Santos IJ, Messika-Zeitoun D, Eltchaninoff H, Kapadia S, Lerakis S, Cheema AN, et al. Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry. Circulation 2015;131:1566–1574. https://doi.org/10.1161/ CIRCULATIONAHA.114.014089 147. Olmos C, Vilacosta I, Fernandez C, Lopez J, Sarria C, Ferrera C, et al. Contemporary epidemiology and prognosis of septic shock in infective endocarditis. Eur Heart J 2013; 34:1999–2006. https://doi.org/10.1093/eurheartj/ehs336 148. Escola-Verge L, Fernandez-Hidalgo N, Larrosa MN, Fernandez-Galera R, Almirante B. Secular trends in the epidemiology and clinical characteristics of Enterococcus faecalis infective endocarditis at a referral center (2007–2018). Eur J Clin Microbiol Infect Dis 2021;40:1137–1148. https://doi.org/10.1007/s10096-020-04117-x 149. Dahl A, Iversen K, Tonder N, Hoest N, Arpi M, Dalsgaard M, et al. Prevalence of infective endocarditis in Enterococcus faecalis bacteremia. J Am Coll Cardiol 2019;74: 193–201. https://doi.org/10.1016/j.jacc.2019.04.059 150. Lamy B, Dargere S, Arendrup MC, Parienti JJ, Tattevin P. How to optimize the use of blood cultures for the diagnosis of bloodstream infections? A state-of-the art. Front Microbiol 2016;7:697. https://doi.org/10.3389/fmicb.2016.00697 151. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30: 633–638. https://doi.org/10.1086/313753 152. La Scola B, Raoult D. Direct identification of bacteria in positive blood culture bottles by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry. PLoS One 2009;4:e8041. https://doi.org/10.1371/journal.pone.0008041 153. Burckhardt I, Zimmermann S. Susceptibility testing of bacteria using MALDI-ToF mass spectrometry. Front Microbiol 2018;9:1744. https://doi.org/10.3389/fmicb.2018.01744 154. Pecoraro AJK, Herbst PG, Pienaar C, Taljaard J, Prozesky H, Janson J, et al. Modified Duke/European Society of Cardiology 2015 clinical criteria for infective endocarditis: time for an update? Open Heart 2022;9:e001856. https://doi.org/10.1136/openhrt- 2021-001856 155. Kong WKF, Salsano A, Giacobbe DR, Popescu BA, Laroche C, Duval X, et al. Outcomes of culture-negative vs. culture-positive infective endocarditis: the ESC-EORP EURO-ENDO registry. Eur Heart J 2022;43:2770–2780. https://doi.org/ 10.1093/eurheartj/ehac307 156. Fournier PE, Gouriet F, Casalta JP, Lepidi H, Chaudet H, Thuny F, et al. Blood culturenegative endocarditis: improving the diagnostic yield using new diagnostic tools. Medicine (Baltimore) 2017;96:e8392. https://doi.org/10.1097/MD.0000000000008392 157. Gouriet F, Samson L, Delaage M, Mainardi JL, Meconi S, Drancourt M, et al. Multiplexed whole bacterial antigen microarray, a new format for the automation of serodiagnosis: the culture-negative endocarditis paradigm. Clin Microbiol Infect 2008;14:1112–1118. https://doi.org/10.1111/j.1469-0691.2008.02094.x 158. Raoult D, Casalta JP, Richet H, Khan M, Bernit E, Rovery C, et al. Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol 2005; 43:5238–5242. https://doi.org/10.1128/JCM.43.10.5238-5242.2005 159. Hajduczenia MM, Klefisch FR, Hopf AGM, Grubitzsch H, Stegemann MS, Pfafflin F, et al. New perspectives for prosthetic valve endocarditis – impact of molecular imaging by fishseq diagnostics. Clin Infect Dis 2023;76:1050–1058. https://doi.org/10.1093/cid/ ciac860 160. Liesman RM, Pritt BS, Maleszewski JJ, Patel R. Laboratory diagnosis of infective endocarditis. J Clin Microbiol 2017;55:2599–2608. https://doi.org/10.1128/JCM.00635-17 161. Loyens M, Thuny F, Grisoli D, Fournier PE, Casalta J-P, Vitte J, et al. Link between endocarditis on porcine bioprosthetic valves and allergy to pork. Int J Cardiol 2013;167: 600–602. https://doi.org/10.1016/j.ijcard.2012.09.233 162. Selton-Suty C, Maigrat CH, Devignes J, Goehringer F, Erpelding ML, Alla F, et al. Possible relationship between antiphospholipid antibodies and embolic events in infective endocarditis. Heart 2018;104:509–516. https://doi.org/10.1136/heartjnl-2017- 312359 163. Habib G, Badano L, Tribouilloy C, Vilacosta I, Zamorano JL, Galderisi M, et al. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr 2010;11:202–219. https://doi.org/10.1093/ejechocard/jeq004 164. Erba PA, Pizzi MN, Roque A, Salaun E, Lancellotti P, Tornos P, et al. Multimodality imaging in infective endocarditis: an imaging team within the endocarditis team. Circulation 2019;140:1753–1765. https://doi.org/10.1161/CIRCULATIONAHA.119.040228 165. Ostergaard L, Vejlstrup N, Kober L, Fosbol EL, Sondergaard L, Ihlemann N. Diagnostic potential of intracardiac echocardiography in patients with suspected prosthetic valve endocarditis. J Am Soc Echocardiogr 2019;32:1558–1564.e3. https://doi.org/10.1016/j. echo.2019.06.016 166. Bai AD, Steinberg M, Showler A, Burry L, Bhatia RS, Tomlinson GA, et al. Diagnostic accuracy of transthoracic echocardiography for infective endocarditis findings using transesophageal echocardiography as the reference standard: a meta-analysis. J Am Soc Echocardiogr 2017;30:639–646.e8. https://doi.org/10.1016/j.echo.2017.03.007 167. Chambers J, Sandoe J, Ray S, Prendergast B, Taggart D, Westaby S, et al. The infective endocarditis team: recommendations from an international working group. Heart 2014;100:524–527. https://doi.org/10.1136/heartjnl-2013-304354 168. Jain V, Wang TKM, Bansal A, Farwati M, Gad M, Montane B, et al. Diagnostic performance of cardiac computed tomography versus transesophageal echocardiography in infective endocarditis: a contemporary comparative meta-analysis. J Cardiovasc Comput Tomogr 2021;15:313–321. https://doi.org/10.1016/j.jcct.2020.11.008 169. Oliveira M, Guittet L, Hamon M, Hamon M. Comparative value of cardiac CT and transesophageal echocardiography in infective endocarditis: a systematic review and meta-analysis. Radiol Cardiothorac Imaging 2020;2:e190189. https://doi.org/10.1148/ ryct.2020190189 170. Palraj BR, Baddour LM, Hess EP, Steckelberg JM, Wilson WR, Lahr BD, et al. Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT): scoring system to guide use of echocardiography in the management of Staphylococcus aureus bacteremia. Clin Infect Dis 2015;61:18–28. https://doi.org/10.1093/cid/civ235 171. Sunnerhagen T, Tornell A, Vikbrant M, Nilson B, Rasmussen M. HANDOC: a handy score to determine the need for echocardiography in non-beta-hemolytic streptococcal bacteremia. Clin Infect Dis 2018;66:693–698. https://doi.org/10.1093/cid/cix880 172. Berge A, Krantz A, Ostlund H, Naucler P, Rasmussen M. The DENOVA score efficiently identifies patients with monomicrobial Enterococcus faecalis bacteremia where echocardiography is not necessary. Infection 2019;47:45–50. https://doi.org/10.1007/ s15010-018-1208-3 173. Bouza E, Kestler M, Beca T, Mariscal G, Rodriguez-Creixems M, Bermejo J, et al. The NOVA score: a proposal to reduce the need for transesophageal echocardiography in patients with enterococcal bacteremia. Clin Infect Dis 2015;60:528–535. https://doi. org/10.1093/cid/ciu872 ESC Guidelines 4025 Downloaded from academic.oup.com/eurheartj/article/44/39/3948/7243107 by guest on 07 October 2026